Vladmir C. Cordeiro de Lima/accamargo.org.br
Mar 4, 2025, 05:19
Vladmir C. Cordeiro de Lima: Frequency and characteristics of ERBB2 mutations in Latin American NSCLC patients
Vladmir C. Cordeiro de Lima, Medical Oncologist at A C Camargo Cancer Center, shared an article by Erick F. Saldanha, et al. on X:
“Our paper describing the frequency and characteristics of ERBB2 mutations in Latin American NSCLC patients is out at The Oncologist!
Mutation rate 2.8% (mostly never smokers). rwOS-25.9 mo.
Congratulatios to Erick Saldanha, Andres F. Cardona and all CLICaP!”
Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP).
Authors: Erick F. Saldanha, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 3, 2025, 01:21
Apr 2, 2025, 19:03
Apr 2, 2025, 18:42
Apr 2, 2025, 18:29
Apr 2, 2025, 18:23
Apr 2, 2025, 18:14
Apr 2, 2025, 18:01